RESEARCH-USE BIOSIMILAR ANTIBODY

Ebronucimab

Monoclonal antibody · IgG1

PCSK9IgG1RUO

Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells.

TARGETPCSK9
YMonoclonal antibody
CATALOGSC-BS-610
CATALOG NUMBERSC-BS-610
MOLECULAR WEIGHTApprox. 144.74 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells.

Ebronucimab is a recombinant research-use antibody directed against PCSK9.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Ebronucimab | StellaCyte